Terms: = Lung cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Prognosis
8 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to myh9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. DNAJA4 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma via PSMD2-mediated myh9 degradation.
Zhang Q; Feng P; Zhu XH; Zhou SQ; Ye ML; Yang XJ; Gong S; Huang SY; Tan XR; He SW; Li YQ
Cell Death Dis; 2023 Oct; 14(10):697. PubMed ID: 37875476
[TBL] [Abstract] [Full Text] [Related]
3. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating myh9-Mediated GSK3β/β-Catenin Signaling.
Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
[TBL] [Abstract] [Full Text] [Related]
4. ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/myh9/USP7/c-Myc axis.
Hou R; Li Y; Luo X; Zhang W; Yang H; Zhang Y; Liu J; Liu S; Han S; Liu C; Huang Y; Liu Z; Li A; Fang W
Int J Biol Sci; 2022; 18(6):2553-2567. PubMed ID: 35414777
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear myh9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
[No Abstract] [Full Text] [Related]
6. Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.
De Rienzo A; Archer MA; Yeap BY; Dao N; Sciaranghella D; Sideris AC; Zheng Y; Holman AG; Wang YE; Dal Cin PS; Fletcher JA; Rubio R; Croft L; Quackenbush J; Sugarbaker PE; Munir KJ; Battilana JR; Gustafson CE; Chirieac LR; Ching SM; Wong J; Tay LC; Rudd S; Hercus R; Sugarbaker DJ; Richards WG; Bueno R
Cancer Res; 2016 Jan; 76(2):319-28. PubMed ID: 26554828
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of myh9 expression in resected non-small cell lung cancer.
Katono K; Sato Y; Jiang SX; Kobayashi M; Nagashio R; Ryuge S; Fukuda E; Goshima N; Satoh Y; Saegusa M; Masuda N
PLoS One; 2015; 10(3):e0121460. PubMed ID: 25826333
[TBL] [Abstract] [Full Text] [Related]
8. Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer.
Xia ZK; Yuan YC; Yin N; Yin BL; Tan ZP; Hu YR
Dis Esophagus; 2012 Jul; 25(5):427-36. PubMed ID: 21951916
[TBL] [Abstract] [Full Text] [Related]
